Drug Early Warning from Re-Testing Biological Samples
The summary for the Drug Early Warning from Re-Testing Biological Samples grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Office of National Drug Control Policy, which is the U.S. government agency offering this grant.
Drug Early Warning from Re-Testing Biological Samples: The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to perform research and analysis of data to inform drug policy. This project seeks to further refine a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations – including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. Similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients. Before the specimens are discarded, the project will re-test them for an expanded panel of drugs, including synthetic cannabinoids, to determine what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography. By passing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality. ONDCP expects to continue to engage the laboratory testing services of the Armed Forces Medical Examiner System (AFMES) at no charge to further minimize project costs.
Federal Grant Title: | Drug Early Warning from Re-Testing Biological Samples |
Federal Agency Name: | Office of National Drug Control Policy |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | ONDCP-DEW-2015 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 95.007 |
CFDA Descriptions: | Research and Data Analysis |
Current Application Deadline: | Sep 22, 2015 |
Original Application Deadline: | Sep 22, 2015 |
Posted Date: | Sep 16, 2015 |
Creation Date: | Sep 16, 2015 |
Archive Date: | Oct 22, 2015 |
Total Program Funding: | $100,000 |
Maximum Federal Grant Award: | $100,000 |
Minimum Federal Grant Award: | $100,000 |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education
- Additional Information on Eligibility
- ONDCP encourages applications from public nonprofit institution/organization (includes institutions of higher education and hospitals). Applicants must have expert knowledge and extensive experience in conducting research and analysis. Current awardee is eligible to apply for this funding opportunity.
- Grant Announcement Contact
- darren neely
IT specialist
Phone 2023955530
email for electronic access problems
Office of National Drug Control Policy 202-395-5530 - Similar Government Grants
- • Emergency Department Substance Use Surveillance System
- • Combating Overdose through Community-Level Intervention
- • Combating Opioid Overdose through Community-Level Intervention
- • Drug Early Warning Signals from High Risk Populations
- • Competitive Cooperative Agreement Solicitation Combating Opioid Overdose through Community...
- More Grants from the Office of National Drug Control Policy
- • Emergency Department Substance Use Surveillance System
- • Combating Overdose through Community-Level Intervention
- • State Judiciary Education on Substance Use and Substance Use Disorder
- • Juvenile and Family Court Judiciary Education on Substance Use and Substance Use Disorder
- • Model Acts 2023